Together with our results that pazopanib increased p53-independent PUMA expression in colon cancer cells (Figure 1), we could explain the synergistic effects of cisplatin on pazopanib-induced apoptosis maybe due to the synergy of PUMA up-regulation through p53-dependent and -independent ways. Here, TP53 is linked to colonic neoplasm.